跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Humalog Kwikpen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Humalog Kwikpen
Approved
STANDARD
Humalog Kwikpen
Eli Lilly Italia S.p.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
93019d2a5b2929c5
Company
Eli Lilly Italia S.p.A.
Type
Standard
Approval Details
Approval Id
93019d2a5b2929c5
Drug Approval Philippines Name
Humalog Kwikpen
Product Name
Humalog Kwikpen
Registration Number
BR-1053
Brand Name
Humalog Kwikpen
Generic Name
Insulin Lispro (rDNA origin)
Dosage Form
Solution for Injection (IM/IV/SC)
Dosage Strength
100 units/mL
Manufacturer
Eli Lilly Italia S.p.A.
Importer
Zuellig Pharma Corporation
Issuance Date
25 October 2022
Expiry Date
25 October 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
93019d2a5b2929c5
Type
Standard
Back to Philippines FDA Approvals